Therapeutics
Search By Attributes
Search Results
| Name | Synonyms | FDA Status | Company | Target Type | Therapy Type | Approved For |
|---|---|---|---|---|---|---|
| AADvac-1 | Axon peptide 108 conjugated to KLH | Alzheimer's Disease (Phase 2), Progressive Nonfluent Aphasia (Phase 1) | Axon Neuroscience SE | Tau | Immunotherapy (active) | |
| ABvac 40 | Alzheimer's Disease (Phase 2) | Araclon Biotech | Amyloid-Related | Immunotherapy (active) | ||
| Affitope AD02 | Alzheimer's Disease (Phase 2) | AFFiRiS AG | Amyloid-Related | Immunotherapy (active) | ||
| UB 311 | Alzheimer's Disease (Phase 2) | United Neuroscience | Amyloid-Related | Immunotherapy (active) |